Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.

MLA

Kong, Xin, et al. “Programmed Death Ligand 1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotypes in Hepatocellular Carcinoma through the Serum and Glucocorticoid Kinase 2/β-Catenin Signaling Pathway.” Cancer Science, vol. 114, no. 6, June 2023, pp. 2265–76. EBSCOhost, https://doi.org/10.1111/cas.15753.

APA

Kong, X., Peng, H., Liu, P., Fu, X., Wang, N., & Zhang, D. (2023). Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway. Cancer Science, 114(6), 2265–2276. https://doi.org/10.1111/cas.15753

Chicago

Kong, Xin, Hong Peng, Peng Liu, Xiao Fu, Ni Wang, and Dazhi Zhang. 2023. “Programmed Death Ligand 1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotypes in Hepatocellular Carcinoma through the Serum and Glucocorticoid Kinase 2/β-Catenin Signaling Pathway.” Cancer Science 114 (6): 2265–76. doi:10.1111/cas.15753.